Taofeek K. Owonikoko

Also affiliated with U-M Rogel Cancer Center, University of Baltimore

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

14.6Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Papers

Driven by 34 papers — median percentile 98. Top paper: “An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics”.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001302

N/A

2.2DataRank · unranked

66 citations

Kristin Higgins, Zhengjia Chen, Gabriel Sica, Conor Steuer, Chao Zhang +12 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004273

N/A

0.753DataRank · unranked

21 citations

Martin Reck, Paul Nghiem, Feng Yan, Gregory E. Plautz, Hye Ryun Kim +10 more

Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial

Cancer Medicine(2020)10.1002/cam4.3416

N/A

0.523DataRank · unranked

9 citations

Fengmin Zhao, Taofeek K. Owonikoko, Josephine Feliciano, Nisha Mohindra, Suzanne E. Dahlberg +10 more

Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor

PLoS ONE(2021)10.1371/journal.pone.0254125

N/A

0.470DataRank · unranked

22 citations

Ramireddy Bommireddy, Luis E. Muñoz, Rohini N. Guin, Changyong Wei, Amanda N. Ruggieri +7 more

Prognostic significance of an invasive leader cell–derived mutation cluster on chromosome 16q

Cancer(2020)10.1002/cncr.32903

N/A

0.312DataRank · unranked

7 citations

Manali Rupji, Bhakti Dwivedi, Jeanne Kowalski, Jessica Konen, Taofeek K. Owonikoko +4 more

Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer

Cancers(2025)10.3390/cancers17030446

N/A

0.189DataRank · unranked

2 citations

Abbe Pannucci, Andrei A. Ivanov, Jeffrey M. Switchenko, Shi‐Yong Sun, Gabriel Sica +5 more

Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancer

The Oncologist(2025)10.1093/oncolo/oyaf284

N/A

0.165DataRank · unranked

2 citations

R. Donald Harvey, Christina Wu, Elise Hitron, Hannah Collins, Suzanne Scott +7 more

A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2697

N/A

0DataRank · unranked

14 citations

R. Donald Harvey, Bradley Curtis Carthon, Zhengjia Chen, Colleen Lewis, Hanna Collins +16 more

Efficacy and safety of immune checkpoint blockade in self‐identified Black patients with advanced non–small cell lung cancer

Cancer(2020)10.1002/cncr.33141

N/A

0DataRank · unranked

24 citations

Subir Goyal, Zhengjia Chen, Anne Engelhart, Jennifer W. Carlisle, Tyler Beardslee +7 more

Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

Cancer(2020)10.1002/cncr.32744

N/A

0DataRank · unranked

48 citations

Guoqing Qian, Dan Zong, Songqing Fan, Taofeek K. Owonikoko, Suresh S. Ramalingam +2 more

NRG Oncology/Alliance LU005: A phase II/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps9082

N/A

0DataRank · unranked

20 citations

Chen Hu, Kristin Higgins, Salma K. Jabbour, David Kozono, Taofeek K. Owonikoko +12 more

KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e21079

N/A

0DataRank · unranked

2 citations

Madhusmita Behera, Conor Steuer, Suchita Pakkala, Jennifer W. Carlisle, Taofeek K. Owonikoko +7 more

Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

Cancer Research(2021)10.1158/0008-5472.can-21-0556

N/A

0DataRank · unranked

67 citations

Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang +7 more

Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR Inhibitors

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0147

N/A

0DataRank · unranked

43 citations

Jianping Guo, Karin A. Vallega, C. Hu, Zhen Chen, Yunfu Deng +7 more

Discovery of Small Molecule Bak Activator for Lung Cancer Therapy

Theranostics(2021)10.7150/thno.60349

N/A

0DataRank · unranked

34 citations

Abu Syed Md Anisuzzaman, Andrew T. Magis, Guo Chen, Maohua Xie, Guojing Zhang +6 more

Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.01.001

N/A

0DataRank · unranked

32 citations

Mary W. Redman, Lauren A. Byers, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +12 more

EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair

Oncogene(2020)10.1038/s41388-020-1332-2

N/A

0DataRank · unranked

57 citations

Matthew Z. Madden, Dongkyoo Park, Elizabeth V. Minten, Priya Kapoor-Vazirani, Erica Werner +17 more

YAP1 transcription factor expression to define subsets of cancers with T-cell inflamed phenotype in a pan-tumor analysis across 33 tumor types.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2610

N/A

0DataRank · unranked

1 citations

Andrei A. Ivanov, Guojing Zhang, Fadlo R. Khuri, Suresh S. Ramalingam, Haian Fu +3 more

Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2972

N/A

0DataRank · unranked

58 citations

Nizar M. Tannir, Othon Iliopoulos, Richard J. Lee, Melinda L. Telli, Alice C. Fan +15 more

MERTK activation drives osimertinib resistance in EGFR-mutant non–small cell lung cancer

Journal of Clinical Investigation(2022)10.1172/jci150517

N/A

0DataRank · unranked

46 citations

Justus M. Huelse, Dmitri Kireev, Zikang Tan, Luxiao Chen, Subir Goyal +10 more

YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell–Inflamed Phenotype

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.11.006

N/A

0DataRank · unranked

165 citations

Bhakti Dwivedi, Zhengjia Chen, Chao Zhang, Benjamin G. Barwick, Vinicius Ernani +13 more

Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis

Cancers(2022)10.3390/cancers14133206

N/A

0DataRank · unranked

7 citations

Chao Zhang, Zhengjia Chen, Camille Ragin, Taofeek K. Owonikoko, Bassel Nazha

Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer

Cancer Medicine(2022)10.1002/cam4.5465

N/A

0DataRank · unranked

3 citations

Yi Lasanajak, David F. Smith, Xuezheng Song, Mohammad Sohrab Hossain, Taofeek K. Owonikoko +1 more

Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast

The Oncologist(2023)10.1093/oncolo/oyad181

N/A

0DataRank · unranked

1 citations

Jeffrey M. Switchenko, Madhusmita Behera, Mehmet Asım Bilen, Taofeek K. Owonikoko, Jonathan L. Kaufman +9 more

Cisplatin-Induced Ototoxicity: A Concise Review of the Burden, Prevention, and Interception Strategies

JCO Oncology Practice(2023)10.1200/op.22.00710

N/A

0DataRank · unranked

91 citations

Masood Pasha Syed, Carissa A. Low, Taofeek K. Owonikoko, Asmi Chattaraj

Data from Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

(2023)10.1158/0008-5472.c.6513256.v1

N/A

0DataRank · unranked

0 citations

Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang +7 more

Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

(2023)10.1158/1078-0432.c.6532368.v1

N/A

0DataRank · unranked

0 citations

Nizar M. Tannir, Othon Iliopoulos, Richard J. Lee, Melinda L. Telli, Alice C. Fan +15 more

SCLC Classification by Platinum Sensitivity in the Era of Immunotherapy: Mere Relic or a Valuable Treasure to Keep?

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2023.11.022

N/A

0DataRank · unranked

3 citations

Taofeek K. Owonikoko

A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-20-1592

N/A

0DataRank · unranked

14 citations

Chioma J. Madubata, Melinda C. Aldrich, Montessa M. Lee, Taofeek K. Owonikoko, John D. Minna +4 more

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.016

N/A

0DataRank · unranked

177 citations

Julie George, Taofeek K. Owonikoko, Anton Berns, Élisabeth Brambilla, Lauren A. Byers +42 more

Taofeek K. Owonikoko

Indexed papers

Top data-sharing exemplar

Papers